drugset / Trial / NCT00227708

Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT00227708 ↗

Phase 2 Completed 58 enrolled UNICANCER
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Chemotherapy drugs may have different effects in older patients. PURPOSE: This phase II trial is studying how well docetaxel works in treating older patients with locally advanced or metastatic non-small cell lung cancer.

Timeline

Start
2005-06
Primary completion
—
Completion
2006-08-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — Intravenous

Indications